These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8519692)

  • 1. Resistance to transforming growth factor beta and activin due to reduced receptor expression in human breast tumor cell lines.
    Kalkhoven E; Roelen BA; de Winter JP; Mummery CL; van den Eijnden-van Raaij AJ; van der Saag PT; van der Burg B
    Cell Growth Differ; 1995 Sep; 6(9):1151-61. PubMed ID: 8519692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responsiveness to transforming growth factor-beta (TGF-beta)-mediated growth inhibition is a function of membrane-bound TGF-beta type II receptor in human breast cancer cells.
    Lynch MA; Petrel TA; Song H; Knobloch TJ; Casto BC; Ramljak D; Anderson LM; DeGroff V; Stoner GD; Brueggemeier RW; Weghorst CM
    Gene Expr; 2001; 9(4-5):157-71. PubMed ID: 11444526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells.
    Arteaga CL; Tandon AK; Von Hoff DD; Osborne CK
    Cancer Res; 1988 Jul; 48(14):3898-904. PubMed ID: 3164252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin.
    Cárcamo J; Weis FM; Ventura F; Wieser R; Wrana JL; Attisano L; Massagué J
    Mol Cell Biol; 1994 Jun; 14(6):3810-21. PubMed ID: 8196624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DPC4 (SMAD4) mediates transforming growth factor-beta1 (TGF-beta1) induced growth inhibition and transcriptional response in breast tumour cells.
    de Winter JP; Roelen BA; ten Dijke P; van der Burg B; van den Eijnden-van Raaij AJ
    Oncogene; 1997 Apr; 14(16):1891-9. PubMed ID: 9150356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of transforming growth factor-beta receptor type II expression in estrogen receptor-positive breast cancer cells through SP1 activation by 5-aza-2'-deoxycytidine.
    Ammanamanchi S; Kim SJ; Sun LZ; Brattain MG
    J Biol Chem; 1998 Jun; 273(26):16527-34. PubMed ID: 9632722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoic acid resistance of estradiol-independent breast cancer cells coincides with diminished retinoic acid receptor function.
    van der Burg B; van der Leede BM; Kwakkenbos-Isbrücker L; Salverda S; de Laat SW; van der Saag PT
    Mol Cell Endocrinol; 1993 Feb; 91(1-2):149-57. PubMed ID: 8386111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of type I receptor specificity by the type II receptors for TGF-beta or activin.
    Ebner R; Chen RH; Lawler S; Zioncheck T; Derynck R
    Science; 1993 Nov; 262(5135):900-2. PubMed ID: 8235612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of activin-dependent transcription by kinase-deficient activin receptors.
    Tsuchida K; Vaughan JM; Wiater E; Gaddy-Kurten D; Vale WW
    Endocrinology; 1995 Dec; 136(12):5493-503. PubMed ID: 7588300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nodal signaling uses activin and transforming growth factor-beta receptor-regulated Smads.
    Kumar A; Novoselov V; Celeste AJ; Wolfman NM; ten Dijke P; Kuehn MR
    J Biol Chem; 2001 Jan; 276(1):656-61. PubMed ID: 11024047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: growth stimulation in the presence of tamoxifen.
    Boylan M; van den Berg HW; Lynch M
    Ann Oncol; 1998 Feb; 9(2):205-11. PubMed ID: 9553667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transforming growth factor beta type II receptor can replace the activin type II receptor in inducing mesoderm.
    Bhushan A; Lin HY; Lodish HF; Kintner CR
    Mol Cell Biol; 1994 Jun; 14(6):4280-5. PubMed ID: 8196664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A widely expressed transmembrane serine/threonine kinase that does not bind activin, inhibin, transforming growth factor beta, or bone morphogenic factor.
    Matsuzaki K; Xu J; Wang F; McKeehan WL; Krummen L; Kan M
    J Biol Chem; 1993 Jun; 268(17):12719-23. PubMed ID: 8389764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-specific expression and alternate splicing of messenger ribonucleic acid encoding activin/transforming growth factor-beta receptors in human pituitary adenomas.
    Alexander JM; Bikkal HA; Zervas NT; Laws ER; Klibanski A
    J Clin Endocrinol Metab; 1996 Feb; 81(2):783-90. PubMed ID: 8636304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type I and type II activin receptors and human erythroid differentiation.
    Lebrun JJ; Vale WW
    Mol Cell Biol; 1997 Mar; 17(3):1682-91. PubMed ID: 9032295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FRA-1 expression level modulates regulation of activator protein-1 activity by estradiol in breast cancer cells.
    Philips A; Teyssier C; Galtier F; Rivier-Covas C; Rey JM; Rochefort H; Chalbos D
    Mol Endocrinol; 1998 Jul; 12(7):973-85. PubMed ID: 9658402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defects of TGF-beta receptor signaling in mammary cell tumorigenesis.
    Brattain MG; Ko Y; Banerji SS; Wu G; Willson JK
    J Mammary Gland Biol Neoplasia; 1996 Oct; 1(4):365-72. PubMed ID: 10887510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct roles of transforming growth factor-β signaling and transforming growth factor-β receptor inhibitor SB431542 in the regulation of p21 expression.
    Koo BH; Kim Y; Je Cho Y; Kim DS
    Eur J Pharmacol; 2015 Oct; 764():413-423. PubMed ID: 26187313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of activin on the growth and morpholgenesis of primary and transformed mammary epithelial cells.
    Liu QY; Niranjan B; Gomes P; Gomm JJ; Davies D; Coombes RC; Buluwela L
    Cancer Res; 1996 Mar; 56(5):1155-63. PubMed ID: 8640777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of transforming growth factor beta type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells.
    Sun L; Wu G; Willson JK; Zborowska E; Yang J; Rajkarunanayake I; Wang J; Gentry LE; Wang XF; Brattain MG
    J Biol Chem; 1994 Oct; 269(42):26449-55. PubMed ID: 7929366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.